5Motzer RJ, Mazumdar M, Bacik J et al. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma[J]. J Clin Oncol,1999,17(8):2530-2540.
6Flanigan RC, Salmon SE, Blumensein BAet al. Nephrectomy followed by interferon alfa-2b with interferon alfa-2b alone for metastatic renal cell cancer[J]. N Engl J Med,2001, 345(23):1655-1659.
7Mickisch GH, Garin A, van Poppel H et al. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal cell carcinoma: a radomized trial[J]. Lancet,2001, 358(9286):966-970.
8Yang JC, Sherry RM, Steinberg SM et al. Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer[J]. J Clin Oncol,2003, 21(16):3127-3132.
9McDermott D, Flaherty L, Clark J et al. A randomized phase III trial of high-dose interleukin-2 (HD IL2) versus subcutaneous( SC )IL2/interferon(IFN) in patients with metastatic renal cell carcinoma(RCC). A Cytokines Working Group Study[C]. Proc Am Soc Clin Oncol,2001,20:172a(abstr685).
10Childs R, Chernoff A, Contentin N et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral blood stem cell transplantation[J]. N Engl J Med,2000, 343(11):750-758.
